‹ ›
MYP_018649
← PREVIOUS NEXT → BACK
Basic Information
FBP
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Anti-Coronavirus ▸ Anti-SARS-CoV-2
Antiviral ▸ Anti-Influenza virus ▸ Anti-Influenza A ▸ Anti-Influenza A virus
Antiviral ▸ Anti-Influenza virus ▸ Anti-Influenza B virus
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
Membrane / Ion-channel modulation ▸ Sodium channel modulation ▸ Sodium channel inhibitor
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
16 amino acids
C87H139N35O18S
Standard
Sequence
RGAHIKGRWKSRCHRF
Physicochemical Analysis
1995.32 Da
12.00
5.92
5.60
0.3702
-1.44
0.40
-0.55
78.52
30.62
0.1250
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
892.84
-8.87
36.0
27.0
67.0
141.0
5.0
15.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0086619 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2 Hemolytic
Turkey red blood cells (RBC)
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0101858 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-SARS-CoV-2 Fusion inhibition
SARS-CoV-2 (HKU001a) | Vero-E6 cells
1.453 μM
IC50
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min
PaperFusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. | Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY. | Emerg Microbes Infect. 2022 Dec;11(1):926-937. | DOI:10.1080/22221751.2022.2051753 | PMID:35259078 PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0102121 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
Virus:A(H1N1)
3.9 μg/mL
IC50
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0118828 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
SARS-CoV-2(Delta):inhibition of infection in Vera-E6 cells
3.9 μg/mL
IC50
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0168401 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
FluB
7.1 μg/mL
IC50
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
FIRST PREV 1 2 3 4 5 NEXT LAST
Showing 5 records on this page · Page 2 of 5